Consistently, higher levels of ACE2 protein were detected in individuals with a Braak-based diagnosis of AD (Fig. 2B), in association with higher Ace2 mRNA levels (Fig. 2B), suggesting a regulation at the transcriptional level. This evidence concerns the gene ACE2 and Alzheimer disease.